Register  /  Login      
  1. Home
  2. Pharma Horizon
  3. Pharma Horizon News from Companies

Pharma Horizon News from Companies

02/27/2018
ACG signs MoU with Applied DNA Sciences to Enhance Capsule Authentication and Traceability Technology for Pharmaceutical and Nutraceutical Industry
02/27/2018
Sanofi to acquire Ablynx for €3.9 Billion
02/27/2018
Pfizer, AbbVie Plan US Capital Investments
02/27/2018
Merck and Viralytics Announce Acquisition Agreement, Expanding Merck’s Leading Immuno-Oncology Pipeline
02/27/2018
Novo Nordisk successfully completes the first phase 3a trial, PIONEER 1, with oral semaglutide
02/27/2018
European Medicines Agency (EMA) Accepts Fremanezumab Marketing Authorization Application
02/26/2018
Clintec International Expands Capabilities with the Accreditation
of the Latest Generation of Medidata Rave EDC
02/11/2018
New i-Series Plus integrated HPLC
02/06/2018
WORLDSymposium Recognizes BioMarin’s Brineura® (cerliponase alfa) with 2018 New Treatment Award
01/23/2018
U.S. Orphan Drug Designation for Benitec Biopharma Limited
01/18/2018
PPD and Quotient Sciences Form Innovative Partnership to Accelerate Pediatric Drug Development
01/18/2018
Charles River Laboratories Acquires KWS BioTest
01/18/2018
Marina Biotech announces agreement for drug development and licensing with Autotelic Bio
01/17/2018
Vaccitech secures £20m Series A with GV, OSI and Sequoia China
01/17/2018
NICE recommended the use of Darzalex®(daratumumab) monotherapy within the Cancer Drugs Fund (CDF) as an option for treating relapsed and refractory multiple myeloma in adults
01/10/2018
Teva Announces Global License Agreement with Alder BioPharmaceuticals

  • Recent Posts